Primary Category:
Treatment Protocols
Disease Category:
Gastrointestinal, Neuroendocrine
Status:
Open
Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas
NCT#02595424
